|
|
???tair.name??? >
???browser.page.title.author???
|
"wang f d"???jsp.browse.items-by-author.description???
Showing items 26-35 of 67 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-02-26T01:59:46Z |
Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan
|
Wang F.D.; Liao C.H.; Lin Y.T.; WANG-HUEI SHENG; Hsueh P.R. |
| 臺大學術典藏 |
2021-02-26T01:59:31Z |
In?vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan
|
Liu J.-Y.;Wang F.-D.;Ho M.-W.;Lee C.-H.;Liu J.-W.;Wang J.-T.;Wang-Huei Sheng;Hseuh P.-R.;Chang S.-C.; Liu J.-Y.; Wang F.-D.; Ho M.-W.; Lee C.-H.; Liu J.-W.; Wang J.-T.; WANG-HUEI SHENG; Hseuh P.-R.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-26T01:59:20Z |
Clinical outcomes and prognostic factors of patients with severe influenza receiving intravenous peramivir salvage therapy in intensive care units
|
Yeh C.-Y.;Wang F.-D.;Chuang Y.-C.;Yang C.-J.;Huang S.-F.;Weng W.-S.;Liaw C.-H.;Wang-Huei Sheng; Yeh C.-Y.; Wang F.-D.; Chuang Y.-C.; Yang C.-J.; Huang S.-F.; Weng W.-S.; Liaw C.-H.; WANG-HUEI SHENG |
| 臺大學術典藏 |
2021-02-26T01:59:15Z |
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018
|
Lee Y.-L.;Lu M.-C.;Shao P.-L.;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Shi Z.-Y.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Chen Y.-H.;Wang-Huei Sheng;Lee C.-M.;Liao M.-H.;Hsueh P.-R.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Liao M.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-02-26T01:59:08Z |
National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Liu P.-Y.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Liao M.-H.; Hsueh P.-R. |
| 國立成功大學 |
2021 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
|
Tsai, H.-Y.;Lee, Y.-L.;Liu, P.-Y.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Cheng, S.-H.;Ko, W.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Chen, Y.-H.;Liao, C.-H.;Hsueh, P.-R. |
| 國立成功大學 |
2021 |
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the
|
Chien, Y.-C.;Lee, Y.-L.;Liu, P.-Y.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Cheng, S.-H.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Chen, Y.-H.;Ko, W.-C.;Hsueh, P.-R. |
| 國立成功大學 |
2021 |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistan
|
Lee, Y.-L.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 臺大學術典藏 |
2020-12-29T03:48:03Z |
Clinical outcomes and prognostic factors of patients with severe influenza receiving intravenous peramivir salvage therapy in intensive care units
|
Yeh C.-Y.;Wang F.-D.;Yu-Chung Chuang;Yang C.-J.;Huang S.-F.;Weng W.-S.;Liaw C.-H.;Sheng W.-H.; Yeh C.-Y.; Wang F.-D.; YU-CHUNG CHUANG; Yang C.-J.; Huang S.-F.; Weng W.-S.; Liaw C.-H.; Sheng W.-H. |
| 臺大學術典藏 |
2020-12-18T08:37:40Z |
Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan
|
Wang F.D.;Liao C.H.;Lin Y.T.;Sheng W.H.;Po-Ren Hsueh; Wang F.D.; Liao C.H.; Lin Y.T.; Sheng W.H.; PO-REN HSUEH |
Showing items 26-35 of 67 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
